目的探讨大前庭水管综合征（EVAS）患者人工耳蜗植入的安全性和效果。方法回顾性分析2010年10月-2014年2月收治的70例EVAS患者的临床资料。结果 70例患者均一次手术成功,术中检测正常,术后无特殊并发症。术后经开机康复训练6个月后,52...目的探讨大前庭水管综合征（EVAS）患者人工耳蜗植入的安全性和效果。方法回顾性分析2010年10月-2014年2月收治的70例EVAS患者的临床资料。结果 70例患者均一次手术成功,术中检测正常,术后无特殊并发症。术后经开机康复训练6个月后,52例年龄≥3岁患者的声场测听言语频率平均听阈为25~40 d B n HL,平均（29.3±2.5）d B n HL。术后1年,10例年龄〈3岁患者的IT-MAIS评分为26~38分,平均（31.9±3.6）分;44例年龄3~10岁患者的MAIS评分为25~40分,平均（35.1±4.3）分。结论伴双耳极重度感音神经性耳聋的EVAS患者行人工耳蜗植入是安全有效的。展开更多
Usher Syndrome(USH)is the most common deaf-blind syndrome,affecting approximately 1 in 6000 people in the deaf population.This genetic condition is characterized by a combination of hearing loss(HL),retinitis pigmento...Usher Syndrome(USH)is the most common deaf-blind syndrome,affecting approximately 1 in 6000 people in the deaf population.This genetic condition is characterized by a combination of hearing loss(HL),retinitis pigmentosa,and,in some cases,vestibular areflexia.Among the subtypes of USH,USH type 1 is considered the most severe form,presenting profound bilateral congenital deafness,vestibular areflexia,and early onset RP.USH type 2 is the most common form,exhibiting congenital moderate to severe HL for low frequencies and severe to profound HL for high frequencies.Conversely,type 3 is the rarest,initially manifesting mild symptoms during childhood that become more prominent in the first decades of life.The dual impact of USH on both visual and auditory senses significantly impairs patients'quality of life,restricting their daily activities and interactions with society.To date,9 genes have been confirmed so far for USH:MYO7A,USH1C,CDH23,PCDH15,USH1G,USH2A,ADGRV1,WHRN and CLRN1.These genes are inherited in an autosomal recessive manner and encode proteins expressed in the inner ear and retina,leading to functional loss.Although non-genetic methods can assist in patient triage and disease extension evaluation,genetic and molecular tests play a pivotal role in providing genetic counseling,enabling appropriate gene therapy,and facilitating timely cochlear implantation(CI).The CRISPR/Cas9 system and viral-based gene replacement therapy have recently emerged as highly promising techniques for treating USH.Regarding drug therapy,PTC-124 and Nb54 have been identified as promising drug interventions for genetic HL in USH.Simultaneously,CI has proven to be critical in the restoration of hearing.This review aims to summarize the genetic and molecular diagnosis of USH and highlight the importance of early diagnosis in Cuzzuol BR et al.Diagnosis and current treatments of USH WJO https://www.wjgnet.com 2 January 19,2024 Volume 11 Issue 1 guiding appropriate treatment strategies and improving patient prognosis.展开更多
目的分析1例表现较为复杂的II型神经纤维瘤病(neurofibromatosis type II,NF2)患者的临床表现、听力康复方法和效果,明确一种特殊类型的NF2听神经瘤的听力重建方法及术后康复效果。方法整理该患者临床表现及既往史,术前检查,临床手术方...目的分析1例表现较为复杂的II型神经纤维瘤病(neurofibromatosis type II,NF2)患者的临床表现、听力康复方法和效果,明确一种特殊类型的NF2听神经瘤的听力重建方法及术后康复效果。方法整理该患者临床表现及既往史,术前检查,临床手术方法及术后随访听力康复效果。结果患者双侧听神经瘤,听力表现为双耳极重度感音神经性听力下降。外周血基因检测未见治病基因突变,考虑为嵌合体。患者右耳为内耳神经鞘膜瘤,且双眼视力极差,右耳行带瘤人工耳蜗植入术,术后通过为期2个月的以家庭为主的听力语言康复,听觉能力分级(CAP)由0分提高到5分。结论NF2临床表现复杂,临床预后差。带有微小的内耳神经鞘膜瘤的NF2患者可以通过带瘤植入人工耳蜗重建听力。展开更多
文摘目的探讨大前庭水管综合征（EVAS）患者人工耳蜗植入的安全性和效果。方法回顾性分析2010年10月-2014年2月收治的70例EVAS患者的临床资料。结果 70例患者均一次手术成功,术中检测正常,术后无特殊并发症。术后经开机康复训练6个月后,52例年龄≥3岁患者的声场测听言语频率平均听阈为25~40 d B n HL,平均（29.3±2.5）d B n HL。术后1年,10例年龄〈3岁患者的IT-MAIS评分为26~38分,平均（31.9±3.6）分;44例年龄3~10岁患者的MAIS评分为25~40分,平均（35.1±4.3）分。结论伴双耳极重度感音神经性耳聋的EVAS患者行人工耳蜗植入是安全有效的。
文摘Usher Syndrome(USH)is the most common deaf-blind syndrome,affecting approximately 1 in 6000 people in the deaf population.This genetic condition is characterized by a combination of hearing loss(HL),retinitis pigmentosa,and,in some cases,vestibular areflexia.Among the subtypes of USH,USH type 1 is considered the most severe form,presenting profound bilateral congenital deafness,vestibular areflexia,and early onset RP.USH type 2 is the most common form,exhibiting congenital moderate to severe HL for low frequencies and severe to profound HL for high frequencies.Conversely,type 3 is the rarest,initially manifesting mild symptoms during childhood that become more prominent in the first decades of life.The dual impact of USH on both visual and auditory senses significantly impairs patients'quality of life,restricting their daily activities and interactions with society.To date,9 genes have been confirmed so far for USH:MYO7A,USH1C,CDH23,PCDH15,USH1G,USH2A,ADGRV1,WHRN and CLRN1.These genes are inherited in an autosomal recessive manner and encode proteins expressed in the inner ear and retina,leading to functional loss.Although non-genetic methods can assist in patient triage and disease extension evaluation,genetic and molecular tests play a pivotal role in providing genetic counseling,enabling appropriate gene therapy,and facilitating timely cochlear implantation(CI).The CRISPR/Cas9 system and viral-based gene replacement therapy have recently emerged as highly promising techniques for treating USH.Regarding drug therapy,PTC-124 and Nb54 have been identified as promising drug interventions for genetic HL in USH.Simultaneously,CI has proven to be critical in the restoration of hearing.This review aims to summarize the genetic and molecular diagnosis of USH and highlight the importance of early diagnosis in Cuzzuol BR et al.Diagnosis and current treatments of USH WJO https://www.wjgnet.com 2 January 19,2024 Volume 11 Issue 1 guiding appropriate treatment strategies and improving patient prognosis.
文摘目的分析1例表现较为复杂的II型神经纤维瘤病(neurofibromatosis type II,NF2)患者的临床表现、听力康复方法和效果,明确一种特殊类型的NF2听神经瘤的听力重建方法及术后康复效果。方法整理该患者临床表现及既往史,术前检查,临床手术方法及术后随访听力康复效果。结果患者双侧听神经瘤,听力表现为双耳极重度感音神经性听力下降。外周血基因检测未见治病基因突变,考虑为嵌合体。患者右耳为内耳神经鞘膜瘤,且双眼视力极差,右耳行带瘤人工耳蜗植入术,术后通过为期2个月的以家庭为主的听力语言康复,听觉能力分级(CAP)由0分提高到5分。结论NF2临床表现复杂,临床预后差。带有微小的内耳神经鞘膜瘤的NF2患者可以通过带瘤植入人工耳蜗重建听力。
